Severity of Maternal Illness in Pregnancy during COVID-19 Pandemic
Abstract
The current coronavirus disease (COVID-19) caused by the SARS-Cov-2 virus, has caused a global pandemic with over 77.5 million confirmed cases and more than 1.7 million deaths as of late December 2020. An overarching question is whether pregnant women are susceptible to COVID-19 infection and increased severity of disease. Physiological and hormonal changes during pregnancy have a significant impact on the immune system, respiratory system, cardiovascular function, and coagulation. These may have positive or negative effects on COVID-19 disease progression. Pregnancy provides a complex challenge for the maternal immune system as it needs to protect the mother against infections while creating immune tolerance of the semi-allogeneic fetus.
References
World Health Organization WHO coronavirus disease (COVID-19) dashboard. 2020. Available at: https:// covid19-who-int.beckerproxy.wustl.edu/
Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol 2017; 17(8): 469-482.
Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63(6): 425-433.
Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2(9): 656-663.
Di Mascio D, Khalil A, Saccone G et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol 2020; MFM 2: 100107.
Wong SF, Chow KM, Leung TN et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004; 191: 292-297.
Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5(3): 266-271.
Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol 2013; 13(1): 23-33.
Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol 2013; 31: 387-411.
Mold JE, Michaelsson J, Burt TD et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008; 322(5907): 1562-65.
Creanga AA, Kamimoto L, Newsome K et al. Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. Am J Obstet Gynecol 2011; 204(6 Suppl 1): S38-45.
Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374(9688): 451-458.
Louie JK, Acosta M, Jamieson DJ et al. California Pandemic Working G. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010; 362(1): 27-35.
Louie JK, Salibay CJ, Kang M et al. Pregnancy and severe influenza infection in the 2013-2014 influenza season. Obstet Gynecol 2015; 125(1): 184-192.
Siston AM, Rasmussen SA, Honein MA et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303(15): 1517-25.
Liu H, Wang LL, Zhao SJ et al. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol 2020; 139: 103122.
Chen L, Li Q, Zheng D et al. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China. N Engl J Med 2020.
Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet 2020; 395(10226): 760-2.
Schwartz DA. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med 2020.
Sutton D, Fuchs K, D’Alton M, Goffman D. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. N Engl J Med 2020.
Elizabeth AN, Wastnedge RM, Reynolds SR et al. Pregnancy and COVID-19. Physiol Rev 2021; 101: 30318.
Badr DA, Mattern J, Carlin A et al. Are clinical outcomes worse for pregnant women >/= 20 weeks’ gestation infected with COVID-19? A multicenter case-control study with propensity score matching. Am J Obstet Gynecol 2020.
Ellington S, Strid P, Tong VT et al. Characteristics of Women of Reproductive Age with LaboratoryConfirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 769-775.
Lumbreras-Marquez MI, Campos-Zamora M, Seifert SM et al. Excess Maternal Deaths Associated With Coronavirus Disease 2019 (COVID-19) in Mexico. Obstet Gynecol 2020; 136: 1114-6.
Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 2020; 76: 14-20.
Stelzig KE, Canepa-Escaro F, Schiliro M et al. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2020; 318(6): L1280-1.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
